Number of the records: 1  

Regulation of NADPH oxidase-mediated superoxide production by acetylation and deacetylation

  1. 1.
    0546151 - FZÚ 2022 RIV CH eng J - Journal Article
    Xia, N. - Tenzer, S. - Lunov, Oleg - Karl, M. - Simmet, T. - Daiber, A. - Münzel, T. - Reifenberg, G. - Förstermann, U. - Li, H.
    Regulation of NADPH oxidase-mediated superoxide production by acetylation and deacetylation.
    Frontiers in Physiology. Roč. 12, Aug. (2021), č. článku 693702. ISSN 1664-042X. E-ISSN 1664-042X
    Institutional support: RVO:68378271
    Keywords : NADPH oxidase * acetylation and deacetylation * oxidative stress
    OECD category: Biochemistry and molecular biology
    Impact factor: 4.755, year: 2021
    Method of publishing: Open access

    Oral treatment of apolipoprotein E-knockout (ApoE-KO) mice with the putative sirtuin 1 (SIRT1) activator resveratrol led to a reduction of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity in the heart. In contrast, the SIRT1 inhibitor EX527 enhanced the superoxide production in isolated human polymorphonuclear granulocytes. In human monocytic THP-1 cells, phorbol ester-stimulated superoxide production was enhanced by inhibitors of histone deacetylases (HDACs including quisinostat, trichostatin A (TSA), PCI34051, and tubastatin A) and decreased by inhibitors of histone acetyltransferases [such as garcinol, curcumin, and histone acetyltransferase (HAT) Inhibitor II]. These results indicate that protein acetylation and deacetylation may represent crucial mechanisms regulating NADPH oxidase-mediated superoxide production.

    Permanent Link: http://hdl.handle.net/11104/0322796

     
    FileDownloadSizeCommentaryVersionAccess
    0546151.pdf13.2 MBCC licencePublisher’s postprintopen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.